Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ANTX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
14 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 34 days ago
Red flags: 1
66 filers reported a long position in ANTX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Vivo Capital, LLC | $15.3M | 3.2M | Unchanged |
| Commodore Capital LP | $14.2M | 2.9M | +25.7% |
| MILLENNIUM MANAGEMENT LLC | $11.2M | 2.3M | +4.3% |
| BlackRock, Inc. | $8.1M | 1.7M | +422.5% |
| Spruce Street Capital LP | $8M | 1.7M | Unchanged |
| Almitas Capital LLC | $7.1M | 1.5M | -0.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | $6M | 1.2M | +22.5% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.8M | 1M | Unchanged |
| CITADEL ADVISORS LLC | $4.6M | 952K | +513.2% |
| Boxer Capital Management, LLC | $3.6M | 749K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.